株探米国株
日本語 英語
エドガーで原本を確認する
0000200406false00002004062026-04-232026-04-230000200406us-gaap:CommonStockMember2026-04-232026-04-230000200406jnj:A1.150NotesDueNovember2028Member2026-04-232026-04-230000200406jnj:A2.700NotesDueFebruary2029Member2026-04-232026-04-230000200406jnj:A3.20NotesDueNovember2032Member2026-04-232026-04-230000200406jnj:A3.050NotesDueFebruary2033Member2026-04-232026-04-230000200406jnj:A1.650NotesDue2035Member2026-04-232026-04-230000200406jnj:A3.350NotesDueNovember2036Member2026-04-232026-04-230000200406jnj:A3.350NotesDueFebruary2037Member2026-04-232026-04-230000200406jnj:A3.550NotesDueNovember2044Member2026-04-232026-04-230000200406jnj:A3.600NotesDueFebruary2045Member2026-04-232026-04-230000200406jnj:A3.700NotesDueFebruary2055Member2026-04-232026-04-23

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): 
April 23, 2026
Johnson & Johnson
(Exact name of registrant as specified in its charter)
New Jersey
1-3215
22-1024240
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
One Johnson & Johnson Plaza, New Brunswick, New Jersey  08933 
(Address of Principal Executive Offices)
 (Zip Code) 
Registrant's telephone number, including area code:
732-524-0400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par Value $1.00
JNJ
New York Stock Exchange
1.150% Notes Due November 2028
JNJ28
New York Stock Exchange
2.700% Notes Due February 2029
JNJ29B
New York Stock Exchange
3.200% Notes Due June 2032
JNJ32
New York Stock Exchange
3.050% Notes Due February 2033
JNJ33B
New York Stock Exchange
1.650% Notes Due May 2035
JNJ35
New York Stock Exchange
3.350% Notes Due June 2036
JNJ36A
New York Stock Exchange
3.350% Notes Due February 2037
JNJ37B
New York Stock Exchange
3.550% Notes Due June 2044
JNJ44
New York Stock Exchange
3.600% Notes Due February 2045
JNJ45
New York Stock Exchange
3.700% Notes Due February 2055
JNJ55
New York Stock Exchange



Item 5.07 Submission of Matters to a Vote of Security Holders.
(a)    The 2026 Annual Meeting of Shareholders of the Company was held on April 23, 2026.
(b)    At the 2026 Annual Meeting of Shareholders, the shareholders:
•elected all 12 Director nominees named in the 2026 Proxy Statement to the Company’s Board of Directors;
•approved, on an advisory basis, the executive compensation philosophy, policies and procedures described in the “Compensation Discussion and Analysis” section of the 2026 Proxy Statement and the compensation of the Company’s executive officers named in the 2026 Proxy Statement, as disclosed therein;
•ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year 2026; and
•did not approve the shareholder proposal to adopt a policy requiring an independent board chair.

The following are the final voting results for each of the four items voted on at the meeting.
1.    Election of Directors:
Shares For
Shares Against
Shares Abstain
Non-Votes
M. C. Beckerle
1,717,960,024
21,523,602
3,071,503
314,406,723
J. A. Doudna
1,722,365,064
17,232,471
2,957,594
314,406,723
J. Duato
1,654,870,358
84,725,734
2,959,037
314,406,723
M. A. Hewson
1,694,721,822
43,362,781
4,470,526
314,406,723
P. A. Johnson
1,724,394,799
15,093,883
3,066,447
314,406,723
H. Joly
1,664,230,485
75,001,172
3,323,472
314,406,723
M. B. McClellan
1,716,126,914
23,153,464
3,274,751
314,406,723
J. G. Morikis
1,722,975,295
16,204,254
3,375,580
314,406,723
D. E. Pinto
1,729,298,557
10,014,607
3,241,965
314,406,723
M. A. Weinberger
1,676,844,107
61,834,491
3,876,531
314,406,723
N. Y. West
1,716,608,777
22,801,606
3,144,746
314,406,723
E. A. Woods
1,682,880,891
56,411,905
3,262,333
314,406,723

2.    Advisory vote to approve named executive officer compensation (Say on Pay):
For
Against
Abstained
Non-Votes
1,641,173,032
91,774,923
9,607,174
314,406,723





3.    Ratification of appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026:
For
Against
Abstained
Non-Votes
1,914,846,474
138,633,899
3,481,479
0

4.    Shareholder Proposal - independent board chair:
For
Against
Abstained
Non-Votes
406,353,048
1,326,857,173
9,344,908
314,406,723

Item 9.01 Financial statements and exhibits
(d)    Exhibits.
Exhibit No. Description of Exhibit
104
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.



Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 27, 2026
JOHNSON & JOHNSON
(Registrant)
By:
/s/ Marc Larkins
Marc Larkins
Corporate Secretary